Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Windtree Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:WINT | Benzinga

Q: What sector and industry does Windtree Therapeutics (WINT) operate in?

Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Windtree Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for WINT.

Open	$0.66
Close	$0.59
Volume / Avg.	448.60K / 2.73M
Day Range	$0.58 - $0.68
52 Wk Range	0.64 - 737.44
Market Cap	$2.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	2.92%
Days to Cover	1

Recent News

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

Rishabh Mishra

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Windtree Therapeutics (WINT) Stock?

Windtree Therapeutics shares are trading higher by 37% during Monday's session. The company regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.66
Close	$0.59
Volume / Avg.	448.60K / 2.73M
Day Range	$0.58 - $0.68
52 Wk Range	0.64 - 737.44
Market Cap	$2.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	2.92%
Days to Cover	1

About Windtree Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage thera...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Windtree Therapeutics (WINT) stock?

You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.

View our list of the best stock brokerages

Who are Windtree Therapeutics (WINT) competitors?

Other companies in Windtree Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Plus Therapeutics (NASDAQ:PSTV), Alzamend Neuro (NASDAQ:ALZN), Bone Biologics (NASDAQ:BBLG) and Entero Therapeutics (NASDAQ:ENTO).

What is the forecast, or price target, for Windtree Therapeutics (WINT) stock?

Windtree Therapeutics has a consensus price target of $7.00.

What is the current price for Windtree Therapeutics (WINT)?

The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.602 last updated June 5, 2025 at 7:55 PM EDT.

Does Windtree Therapeutics (WINT) pay a dividend?

There are no upcoming dividends for Windtree Therapeutics.

When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?

Windtree Therapeutics’s Q1 earnings are confirmed for Monday, August 18, 2025.

Is Windtree Therapeutics (WINT) going to split?

There is no upcoming split for Windtree Therapeutics.

What sector and industry does Windtree Therapeutics (WINT) operate in?

Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Windtree Therapeutics Stock Price, Quotes and Forecasts

Windtree Therapeutics (WINT) Forecast